Barclays analyst Stephanie Davis lowered the firm’s price target on Walgreens Boots Alliance to $11 from $15 and keeps an Underweight rating on the shares. The company cut its fiscal 2024 earnings guidance on continued macro headwinds, which it expects to persist to fiscal 2025, the analyst tells investors in a research note.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WBA:
- Who Owns Walgreens Boots Alliance Stock (WBA)?
- Walgreens Boots Alliance Inc. Reports Earnings: Did it Beat Estimate Forecasts?
- WBA Earnings: Walgreens Crumbles on Lowered Outlook
- Walgreens Boots Alliance Fiscal Quarter Results Webcast
- Options Volatility and Implied Earnings Moves Today, June 27, 2024